Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Thermo Fisher Scientific    TMO

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 76 14190 093130 270164 454--
Entreprise Value (EV)1 95 814106 980145 623177 113177 723176 512
P/E ratio 34,0x30,9x35,4x37,1x32,5x27,2x
Yield 0,32%0,30%0,23%0,21%0,23%0,25%
Capitalization / Revenue 3,64x3,70x5,10x5,86x5,49x5,24x
EV / Revenue 4,58x4,39x5,70x6,32x5,94x5,62x
EV / EBITDA 18,1x17,4x22,3x22,8x21,4x20,2x
Price to Book 3,00x3,26x4,38x5,15x4,97x5,15x
Nbr of stocks (in thousands) 400 995402 576400 991395 589--
Reference price (USD) 190224325416416416
Last update 01/31/201801/30/201901/30/202007/23/202007/23/202007/23/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 20 91824 35825 54228 04129 93531 413
EBITDA1 5 2996 1416 5377 7568 3128 756
Operating profit (EBIT)1 4 8605 6155 9737 0127 5727 908
Operating Margin 23,2%23,1%23,4%25,0%25,3%25,2%
Pre-Tax Profit (EBT)1 2 4293 2624 0704 6985 3807 106
Net income1 2 2252 9383 6964 4565 0725 930
Net margin 10,6%12,1%14,5%15,9%16,9%18,9%
EPS2 5,597,249,1711,212,815,3
Dividend per Share2 0,600,680,760,880,951,03
Last update 01/31/201801/30/201901/30/202007/28/202007/28/202007/28/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 19 67316 88715 35312 65813 26812 058
Net Cash position1 ------
Leverage (Debt / EBITDA) 3,71x2,75x2,35x1,63x1,60x1,38x
Free Cash Flow1 3 4973 7854 0474 6055 5646 463
ROE (Net Profit / Equities) 16,1%17,0%17,4%19,2%20,1%21,4%
Shareholders' equity1 13 83717 25921 26923 18125 27127 734
ROA (Net Profit / Asset) 7,37%8,00%8,70%10,8%9,73%13,9%
Assets1 30 20636 74842 50241 31252 14742 665
Book Value Per Share2 63,368,674,280,783,680,7
Cash Flow per Share2 10,111,212,315,116,819,1
Capex1 5087589261 2221 066900
Capex / Sales 2,43%3,11%3,63%4,36%3,56%2,87%
Last update 01/31/201801/30/201901/30/202007/28/202007/28/202007/28/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
164 454 425 368
Net sales (USD)
25 542 000 000
Number of employees
75 000
Sales / Employee (USD)
340 560
Free-Float
90,4%
Free-Float capitalization (USD)
148 687 253 595
Avg. Exchange 20 sessions (USD)
578 176 870
Average Daily Capital Traded
0,35%
EPS & Dividend